Drug intelligence / Profile preview

(S)-warfarin

Development stage
Unknown
Lead developer
Bristol Myers Squibb
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

(S)-Warfarin is the S-enantiomer of warfarin, a vitamin K antagonist used as an anticoagulant medication. It is the more potent enantiomer in the racemic warfarin mixture, being 2.7 to 3.8 times more potent than the R-enantiomer. (S)-Warfarin works by inhibiting vitamin K epoxide reductase, preventing the recycling of vitamin K and thus interfering with the synthesis of vitamin K-dependent clotting factors (II, VII, IX, and X) and regulatory proteins C and S. This S-enantiomer is primarily metabolized by the CYP2C9 enzyme in the liver, making drug interactions affecting this pathway particularly significant.

Other names
S-warfarin
02

Targets

VKORC1 (Vitamin K epoxide reductase complex subunit 1)

Beyond the preview

Go deeper on (S)-warfarin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (S)-warfarin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call